Search
mobile logo
Title Image

LSKB Attending Bio Europe Spring in Stockholm

WRITTEN BY:

RELATED POSTS

Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Elevar Therapeutics Acquires Global Rights to European Approved Apealea® from Oasmia Pharmaceutical
Elevar Therapeutics Announces Enrollment of the First Patient in a Pivotal Trial for the Treatment of Adenoid Cystic Cancer (ACC)
Elevar Announces Results from the ANGEL trial, a study of Monotherapy Rivoceranib (Apatinib) in Late-Stage Gastric Cancer Patients
South San Francisco U.S.

400 Oyster Point Blvd, Suite 214
South San Francisco, CA 94080
U.S.A.

Salt Lake City U.S. [Headquarters]

2825 E Cottonwood Pkwy Suite 180,
Salt Lake City, UT 84121
U.S.A.

Phone: 801-303-7440
Fax: 801-303-7455

South Korea

7F Mayple Tower, Teheran-ro 420,
Gangnam-gu, Seoul 06193
Republic of Korea

Ireland

The Black Church,
St Mary’s Place,
Dublin, D07 P4AX,
Ireland

Phone: 353-1-969-6739
Fax: 353-1-685-3040

© Copyright 2020 Elevar Therapeutics